How many insider trades does FilingIQ track for OPK?

FilingIQ tracks 4,117 Form 4 insider transactions for OPK (OPKO HEALTH, INC.), covering filings from Dec 21, 2011 onwards. 2 of those were filed in the last 90 days.

Are OPK insiders net buyers or net sellers?

Across the full Form 4 history for OPK, 4,009 transactions (97%) were open-market purchases and 6 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does OPK insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is OPK in?

OPKO HEALTH, INC. (OPK) is classified in the Healthcare sector, specifically Diagnostics & Research, with a current market capitalisation of $911.66M.

OPK insider trading

NasdaqGS Healthcare

OPKO HEALTH, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

4,117

Last 90 days

Buys / sells

97% / 0%

Market cap

$911.66M

About OPKO HEALTH, INC.

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offer laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test services. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency. This segment also develops multi-specific immune therapies focused on oncology, immunology, and infectious diseases; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and related obesity; Somatrogon (hGH-CTP), a once-weekly human growth hormone injection; and Factor VIIa-CTP, a novel long-acting coagulation factor to treat hemophilia. In addition, it develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins or peptides; develops and produces specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and markets, distributes, and sells pharmaceutical products for a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. The company also operates pharmaceutical platforms in Spain, Ireland, Chile, and Mexico. OPKO Health, Inc. was founded in 2007 and is headquartered in Miami, Florida.

Company website: www.opko.com

OPK insider activity at a glance

FilingIQ has scored 4,117 insider transactions for OPK since Dec 21, 2011. The most recent filing in our index is dated Mar 20, 2026.

Across the full history, 4,009 open-market purchases and 6 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on OPK insider trades is 46.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live OPK trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Politicians who have traded OPK

Curbelo, Carlos Mr

U.S. Rep. , FL · 51 trades

Frequently asked

How many insider trades does FilingIQ track for OPK?: FilingIQ tracks 4,117 Form 4 insider transactions for OPK (OPKO HEALTH, INC.), covering filings from Dec 21, 2011 onwards. 2 of those were filed in the last 90 days.
Are OPK insiders net buyers or net sellers?: Across the full Form 4 history for OPK, 4,009 transactions (97%) were open-market purchases and 6 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does OPK insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is OPK in?: OPKO HEALTH, INC. (OPK) is classified in the Healthcare sector, specifically Diagnostics & Research, with a current market capitalisation of $911.66M.

Methodology & sources

Every OPK insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.